Showing 161 - 180 results of 1,337 for search '"Fibrosis"', query time: 0.05s Refine Results
  1. 161
  2. 162
  3. 163

    Improvement of nutrient absorption may enhance systemic oxidative stress in cystic fibrosis patients by Galina V. Shmarina, Alexander L. Pukhalsky, Svetlana N. Kokarovtseva, Daria A. Pukhalskaya, Elena A. Kalashnikova, Nikolaï I. Kapranov, Natalia J. Kashirskaja

    Published 2001-01-01
    “…Background: The life expectancy of patients with cystic fibrosis (CF) is largely dependent on the pulmonary disease severity and progress. …”
    Get full text
    Article
  4. 164
  5. 165

    Spirometry-Related Pain and Distress in Adolescents and Young Adults with Cystic Fibrosis: The Role of Acceptance by Annabelle Casier, Liesbet Goubert, Tine Vervoort, Marleen Theunis, Danielle Huse, Frans De Baets, Dirk Matthys, Geert Crombez

    Published 2013-01-01
    “…OBJECTIVE: To investigate the occurrence of spirometry-related pain and distress in adolescents and young adults with cystic fibrosis (CF), and to investigate the role of acceptance of illness in spirometry-related pain and distress.…”
    Get full text
    Article
  6. 166

    Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis by Toru Arai, Masaki Hirose, Yoshimasa Hamano, Tomoko Kagawa, Akihiro Murakami, Hiroshi Kida, Atsushi Kumanogoh, Yoshikazu Inoue

    Published 2022-01-01
    “…We have previously analysed serum autoantibody levels in patients with idiopathic pulmonary fibrosis (IPF), idiopathic nonspecific interstitial pneumonia (iNSIP), and healthy controls and identified the autoantibody against anti-myxovirus resistance protein-1 (MX1) to be a specific autoantibody in iNSIP. …”
    Get full text
    Article
  7. 167

    Sternum Length and Rib Cage Dimensions Compared with Bodily Proportions in Adults with Cystic Fibrosis by Louis-Philippe Laurin, Vincent Jobin, François Bellemare

    Published 2012-01-01
    “…BACKGROUND: A greater structural expansion of the rib cage in females compared with males has been described in cystic fibrosis (CF) patients; however, conflicting data exist as to whether an elongation of the bony ribs and sternum contributes to this expansion.…”
    Get full text
    Article
  8. 168

    Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment by Morgan T. Sutton, David Fletcher, Santosh K. Ghosh, Aaron Weinberg, Rolf van Heeckeren, Sukhmani Kaur, Zhina Sadeghi, Adonis Hijaz, Jane Reese, Hillard M. Lazarus, Donald P. Lennon, Arnold I. Caplan, Tracey L. Bonfield

    Published 2016-01-01
    “…Cystic fibrosis (CF) is a genetic disease in which the battle between pulmonary infection and inflammation becomes the major cause of morbidity and mortality. …”
    Get full text
    Article
  9. 169
  10. 170
  11. 171

    Human Liver-Derived Stem Cells Improve Fibrosis and Inflammation Associated with Nonalcoholic Steatohepatitis by Stefania Bruno, Maria Beatriz Herrera Sanchez, Chiara Pasquino, Marta Tapparo, Massimo Cedrino, Ciro Tetta, Giovanni Camussi

    Published 2019-01-01
    “…In particular, HLSC treatment induced a reduction of liver fibrosis and inflammation at morphological and molecular levels. …”
    Get full text
    Article
  12. 172
  13. 173

    Rapidly Progressive Pulmonary Apical Fibrosis and Parenchymal Destruction in a Patient with Ankylosing Spondylitis by Hasan Ulusoy, Nazmiye Tibel Tuna, Aslı Tanrivermis Sayit

    Published 2020-01-01
    “…Pulmonary apical fibrosis is a rare complication of ankylosing spondylitis (AS). …”
    Get full text
    Article
  14. 174

    SAA3 deficiency exacerbates intestinal fibrosis in DSS-induced IBD mouse model by Xiaodong Zou, Tong Wu, Jianjiao Lin, Tao Su, Hui Xiao, Chuyan Ni, Lijuan Hu, Wenchu Lin, Weilin Chen, Richard D. Ye, Li Xiang

    Published 2025-01-01
    “…Abstract Intestinal fibrosis, as a late-stage complication of inflammatory bowel disease (IBD), leads to bowel obstruction and requires surgical intervention, significantly lowering the quality of life of affected patients. …”
    Get full text
    Article
  15. 175

    Efficacy of Novel Noncontrast Cardiac Magnetic Resonance Methods in Indicating Fibrosis in Hypertrophic Cardiomyopathy by Maedeh Sharifian, Nahid Rezaeian, Sanaz Asadian, Ali Mohammadzadeh, Ali Nahardani, Kianosh Kasani, Yaser Toloueitabar, Ali Mohammad Farahmand, Leila Hosseini

    Published 2021-01-01
    “…In hypertrophic cardiomyopathy (HCM), myocardial fibrosis is routinely shown by late gadolinium enhancement (LGE) in cardiac magnetic resonance (CMR) imaging. …”
    Get full text
    Article
  16. 176

    Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease by Hongjie Ou, Yaojie Fu, Wei Liao, Caixia Zheng, Xiaolu Wu

    Published 2019-01-01
    “…We aimed at analyzing the role of smoking in hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) and at exploring the related risk factors. …”
    Get full text
    Article
  17. 177
  18. 178
  19. 179

    Noninvasive Methods, including Transient Elastography, for the Detection of Liver Disease in Adults with Cystic Fibrosis by Matthew D Sadler, Pam Crotty, Linda Fatovich, Stephanie Wilson, Harvey R Rabin, Robert P Myers

    Published 2015-01-01
    “…BACKGROUND: Liver disease is the third leading cause of mortality in patients with cystic fibrosis (CF). However, detection of CF-associated liver disease (CFLD) is challenging.…”
    Get full text
    Article
  20. 180